The Propel Contour 50011 Sinus Implant provides sustained release of mometasone furoate via a bioabsorbable sinus implant
Mometasone furoate is a hydrophobic drug that is practically insoluble in water
Some sinus implants help decrease inflammation and open the sinus passageway after sinus surgery
More Informationa
The Propel sinus implant, the Propel Mini Steroid-Releasing Implant, and the Propel Contour devices have been approved by the U
6, 2021, Medtronic has acquired Intersect ENT's PROPEL™ and SINUVA™ (mometasone furoate) sinus implant product lines and technology, intellectual property, PROPEL™, PROPEL™ Mini, and PROPEL™ Contour implants are FDA approved in the U
PROPEL Mini features an innovative 2-in-1 mechanism that opens the sinuses while delivering mometasone furoate directly where it is needed, improving outcomes of both frontal and ethmoid sinus surgeries
muscle weakness, tired feeling, depression, anxiety, or feeling irritable
and PROPEL Contour for the frontal/maxillary sinus ostia
Mometasone nasal (for the nose) is used to prevent seasonal Maximum improvement in symptoms following inhaled administration of mometasone furoate may not be achieved for 1 to 2 weeks or longer after starting treatment